SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012344
Filing Date
2022-08-05
Accepted
2022-08-05 07:31:51
Documents
66
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220630x10q.htm   iXBRL 10-Q 955790
2 EX-10.1 tmb-20220630xex10d1.htm EX-10.1 75484
3 EX-31.1 tmb-20220630xex31d1.htm EX-31.1 14524
4 EX-31.2 tmb-20220630xex31d2.htm EX-31.2 14547
5 EX-32.1 tmb-20220630xex32d1.htm EX-32.1 7200
6 EX-32.2 tmb-20220630xex32d2.htm EX-32.2 7169
7 GRAPHIC tmb-20220630xex10d1001.jpg GRAPHIC 2940
  Complete submission text file 0001558370-22-012344.txt   4551347

Data Files

Seq Description Document Type Size
8 EX-101.SCH tmb-20220630.xsd EX-101.SCH 41294
9 EX-101.CAL tmb-20220630_cal.xml EX-101.CAL 39120
10 EX-101.DEF tmb-20220630_def.xml EX-101.DEF 133300
11 EX-101.LAB tmb-20220630_lab.xml EX-101.LAB 349596
12 EX-101.PRE tmb-20220630_pre.xml EX-101.PRE 252883
60 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220630x10q_htm.xml XML 634619
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

IRS No.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39580 | Film No.: 221138611
SIC: 2834 Pharmaceutical Preparations